Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, November 25, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
ARI Launches New Assay Prep System for Drug Discovery
Tuesday, November 06, 2012
Non-contact dispenser sets a new benchmark for flexible, low-volume assay assembly.

World Exclusives at LAB INNOVATIONS
Wednesday, October 03, 2012
Launch of Cambridge Reactor Design’s new Polar Bear Plus family of products.

TTP Labtech Previews New Tools at ICCBM
Wednesday, September 19, 2012
Precision automated liquid handling portfolio further expands.

Connect with Takara Bio Europe at ELRIG Drug Discovery 2012
Tuesday, September 04, 2012
Connect with Takara Bio at booth M3 at the DD2012 in Manchester and win a Google Nexus 7 tablet.

Free Video Series Explores Crystallization’s Benefits
Monday, August 06, 2012
New videos explore technologies for optimized crystallization processes.

Agilent Technologies Launches New X-ray Diffractometer for Structural Biology Applications
Monday, July 30, 2012
This revolutionary new instrument will be used for collection of high-quality diffraction data from crystalline samples of biological macromolecules.

TTP Labtech Previews New Product for Crystallography Users at ACA
Tuesday, July 24, 2012
Company will be exhibiting at the American Crystallographic Association from 28 July to 1 August.

Zetasizer µV Used in Measuring Protein Structural Transition
Friday, July 20, 2012
UNAM uses dynamic light scattering for allosteric transition characterization.

Linkam Scientific Instruments report on the use of their LTS350 stage at the University of Leeds
Wednesday, June 27, 2012
University uses Linkam instrument to visualise and grow HEW lysozyme crystals.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 233
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv